Sabin Vaccine Institute Receives $13.8M Bill & Melinda Gates Foundation Grant To Pursue Bivalent Hookworm Vaccination Strategy

WASHINGTON, Sept. 14 /PRNewswire/ -- The Sabin Vaccine Institute (SVI) announced today a $13.79 million grant from the Bill & Melinda Gates Foundation for vaccine research and development integral to its Human Hookworm Vaccine Initiative (HHVI). Researchers undertaking clinical trials of a human hookworm vaccine will next pursue development and clinical evaluation of a complementary vaccine candidate, made possible by the newly awarded funding.